Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Benefits seen with rhLAMAN in patients with alpha-mannosidosis

Sep. 26, 2012

Sequestosome-1 identified as a biomarker of melanoma

Sep. 25, 2012

Eliglustat efficacy maintained for 4 years in patients with Gaucher's disease

Sep. 25, 2012

First-in-human study of Opal-HIV-Gag(c) terminated

Sep. 25, 2012

Itraconazole shows promise as an antiangiogenic and antitumor agent

Sep. 25, 2012

Bayer College of Medicine presents novel Ndufs4-mutant mouse model

Sep. 21, 2012

Plasma serotonin as indicator of stable heart disease outcomes

Sep. 21, 2012

Identification of a new series of potent and selective NS5B inhibitors

Sep. 21, 2012

Theravance presents new dual MABA bronchodilators for COPD

Sep. 21, 2012

Afatinib demonstrates significant improvements in PFS in the LUX-lung 3 phase III trial

Sep. 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...